mRNA |
ML239 |
CTRPv2 |
pan-cancer |
AAC |
-0.014 |
0.7 |
mRNA |
Doxorubicin |
CTRPv2 |
pan-cancer |
AAC |
-0.012 |
0.7 |
mRNA |
carboplatin:UNC0638 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.015 |
0.7 |
mRNA |
purmorphamine |
CTRPv2 |
pan-cancer |
AAC |
0.015 |
0.7 |
mRNA |
crizotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.014 |
0.7 |
mRNA |
BRD-K27188169:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.02 |
0.7 |
mRNA |
quizartinib |
CTRPv2 |
pan-cancer |
AAC |
0.014 |
0.7 |
mRNA |
pifithrin-mu |
CTRPv2 |
pan-cancer |
AAC |
-0.013 |
0.7 |
mRNA |
5-FU |
CTRPv2 |
pan-cancer |
AAC |
0.013 |
0.7 |
mRNA |
SR8278 |
CTRPv2 |
pan-cancer |
AAC |
-0.049 |
0.7 |